Search results
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax Dive Continues As FDA Reviews New Covid Shot Information
Investor's Business Daily· 2 years agoThree days after Food and Drug Administration advisors endorsed authorization for Novavax's Covid...
Could Novavax Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting...
Novavax Is a Step Behind, Again. Should You Be Worried?
Motley Fool· 8 months agoIn the earliest days of the coronavirus vaccine race, Novavax (NASDAQ: NVAX) stood out as a...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Is There Any Hope for Novavax?
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has brought investors extreme gains and extreme losses in just a few years. Since, Novavax shares have made their way...
Novavax Won a Nod From FDA Advisors. Now What?
Motley Fool· 2 years agoIt's the moment Novavax (NASDAQ: NVAX) and its investors have been waiting for. A U.S. Food and Drug Administration (FDA) advisory panel voted for the...
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
Fortune via Yahoo Finance· 2 years agoOn Wednesday, the U.S. Centers for Disease Control (CDC) approved the COVID-19 vaccine from...
The Fall Vaccination Season Is Here. Is Novavax a Buy?
Motley Fool· 7 months agoNovavax (NASDAQ: NVAX) fell behind in the original coronavirus vaccine race as rivals Pfizer and...
Down 85%, Is There Any Hope for This Struggling Vaccine Stock?
Motley Fool· 2 years agoIn the early days of the pandemic, if there was one coronavirus vaccine stock investors were betting...
